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Abstract  76 
Significant technical advancements in phosphopeptide enrichment have enabled the 77 
identification of thousands of p-peptides (mono and multiply phosphorylated) in a single 78 
experiment. However, it is still not possible to enrich all p-peptide species in a single 79 
step. A range of new techniques and materials has been developed, with potential to 80 
provide a step-change in phosphopeptide enrichment. The first half of this review 81 
contains a tutorial for new potential phosphoproteomic researchers; discussing the key 82 
steps of a typical phosphoproteomic experiment used to investigate canonical 83 
phosphorylation sites (serine, threonine and tyrosine). The latter half then show-cases 84 
the latest developments in p-peptide enrichment including: i) Strategies to mitigate 85 
non-specific binding in immobilized metal ion affinity chromatography and metal oxide 86 
affinity chromatography protocols; ii) Techniques to separate multiply phosphorylated 87 
from monophosphorylated peptides (including canonical from non canonical 88 
phosphorylated peptides), or to simultaneously co-enrich other post-translational 89 
modifications; iii) New hybrid materials and methods directed towards enhanced 90 
selectivity and efficiency of metal-based enrichment; iv) Novel materials that hold 91 
promise for enhanced phosphotyrosine enrichment. A combination of well-understood 92 
techniques and materials is much more effective than any technique in isolation; but the 93 
field of phosphoproteomics currently requires benchmarking of novel materials against 94 
current methodologies fully evaluate their utility in peptide based proteoform analysis.  95 
Key words: phosphoproteoform, canonical and non-canonical phosphorylation, 96 
enrichment, optimization, phosphoproteomics, phosphopeptide 97 
1. Introduction 98 
1.1 Biological significance of protein phosphorylation 99 
Reversible phosphorylation is one of the most important post-translational 100 




and widespread process, phosphorylation regulates protein ‘behaviour in almost every 102 
conceivable way’ as noted by in ‘The regulation of protein function by multisite 103 
phosphorylation - a 25 year update’ by Professor Sir Philip Cohen in 2000 [2]. 104 
Phosphorylation essentially acts as a molecular switch, effecting temporal and spatial 105 
changes in protein function [3], with 30% proteins estimated to undergo 106 
phosphorylation [2]. Phosphorylation occurs at single (mono-) or multiple (multi-) sites 107 
and can co-occur with other PTM types to generate different ‘proteoforms’. 108 
Phosphoproteoforms form a subset of the ‘epiproteome’: a term encompassing PTM, 109 
sequence and splice isoform variants encoded by a single gene [4]. Given the key role of 110 
phosphorylation in regulating protein function, global site-specific phosphorylation 111 
analysis provides a mechanistic understanding of cellular processes. The ideal method 112 
would be universal ie characterize all protein phosphoproteoforms within a given 113 
sample or sample set. This analytical approach is termed phosphoproteomic analysis: 114 
with focus on the subset of proteins in the proteome that are subject to 115 
phosphorylation.  116 
Current approaches for the analysis of phosphosites predominately employ ‘bottom up’ 117 
mass spectrometry (MS) based techniques for p-peptide analysis. In this approach 118 
p-peptides are either present endogenously or derived by a proteolytic digestion, step 119 
during sample processing (see Tutorial, section 2.5). Complex mixtures of p-peptides are 120 
analysed in a discovery-focused ‘bottom up’ approach, which couples liquid 121 
chromatography (LC) with tandem MS (LC-MS/MS). The reader is referred to an article 122 
by Wilson et al, 2018 [5], which explains the principles and key steps of 123 
phosphoproteomic analysis in a way designed to engage readers without prior 124 
knowledge. Discovery phosphoproteomics can operate in quantitative mode for 125 
comparative sample analysis. This is achieved by coupling p-peptide enrichment with 126 
‘standard’ quantitative proteomic LC-MS/MS workflow coupled to p-peptides 127 
enrichment methods, see Tutorial section 2.8. Quantitative proteomic workflows include 128 




(SILAC) or the use of isobaric chemical tags such as Tandem Mass Tags (TMT) and 130 
isobaric tags for relative and absolute quantification (iTRAQ) [6]. To date, the 131 
identification of phospho-serine/threonine (pSer/pThr) sites using MS technique has 132 
improved, but the determination of tyrosine (pTyr) sites is challenging because the 133 
abundance of pTyr is significantly lower than that of pSer/pThr [3]. The field of 134 
phosphoproteomic applications is wide and publications are numerous and thus we 135 
select specific examples to illustrate key principles and developments, signposting to 136 
publications that provide step by step protocols to guide users in the application of 137 
established protocols (see sections 1.4 and 2.7). 138 
1.2 Phosphoproteomics: Technical challenges and the need for p-peptide enrichment 139 
The analysis of protein phosphorylation poses significant technical challenges both at 140 
the level of sample preparation, and during the subsequent MS analysis. 141 
Phosphoproteoforms are typically present in low abundance relative to their 142 
non-phosphorylated counterparts, due to the occurrence of phosphorylation at sub 143 
stoichiometric levels in biological samples. Phosphorylated peptides tend to have low 144 
ionisation efficiency due to (i) phosphate groups tending to lose protons to carry 145 
negative charges, and (ii) the background presence of large amounts of 146 
unphosphorylated peptides [6]. Selective phospho-enrichment is thus essential and 147 
critical to success, enabling large-scale phosphoproteomic analysis. P-peptide 148 
enrichment is the first step in phosphorylation site analysis (Fig 1a). Nanoflow LC-MS/MS 149 
and data processing generate both the amino acid sequence (thus protein identity) and 150 
characterization of phosphorylation sites [7]. Data processing can be performed using 151 
publicly or commercially available bioinformatic tools [8, 9]. To support assessing these 152 
datasets, a range of tools that allow visualization of quantitative PTM proteomic 153 




1.3 Overview of a phosphoproteomic workflow – key steps 155 
It is currently possible to identify thousands of different phosphorylation sites within a 156 
single phosphoproteomic experiment. The experimental workflow involves 7 key steps: 157 
1) protein extraction; 2) proteolytic digestion; 3) p-peptide enrichment; 4) fractionation; 158 
5) LC-MS/MS; 6) data analysis; 7) biological inference, as explained in a review article by 159 
Riley and Coon in 2015 [11]. The analysis of protein phosphorylation poses significant 160 
technical challenges both at the level of sample preparation, and during the subsequent 161 
mass spectrometry analysis, as reviewed by Leitner et al., 2016 [7].  162 
1.4 Current practice for p-peptide enrichment 163 
Methods employing affinity-based p-peptide enrichment selectively bind the negatively 164 
charged phosphate groups (phosphorylated site) of the p-peptide to metal ions or metal 165 
oxide. These methods are termed Immobilized Metal Ion Affinity Chromatography 166 
(IMAC) and Metal Oxide Affinity Chromatography (MOAC), respectively. There are 3 167 
main steps in the protocol: (1) Incubation: capture of negatively charged phosphate 168 
groups; (2) Washing: removal of non-specific binding. (3) Elution: release of bound 169 
p-peptides (Fig. 1c). Figures showing typical p-peptide enrichment strategies are 170 
included for both IMAC (Fig 2.) and MOAC (Fig 3.) Fe3+ and Ga3+ are the most common 171 
ions used for IMAC enrichment, although additional metal ions have emerged over time. 172 
In MOAC, TiO2 still is the most commonly used metal oxide, and shows a strong binding 173 
efficiency for p-peptides [14]. The range of metal ions employed for IMAC/MOAC are 174 
detailed in supporting Tables S1A, S1B. Numerous efforts have been directed towards 175 
improving the specificity and sensitivity of IMAC from different aspects. These include 176 
the optimization of operating protocols and the development/testing of novel metal 177 
ions, for efficient binding and effective affinity resins [7, 12, 13].  178 
Elution of p-peptide requires disruption of the binding between the phosphate group 179 
and substrate that is based on reversible Lewis acid-base interaction [12, 13, 19, 20]. 180 




the negatively charged phosphate with a high pH, basic buffer, or by incremental 182 
step-wise pH; however, highly acidic solutions have also been employed [18]. When 183 
considering these two approaches, IMAC studies generally result in higher detection of 184 
multi-p-peptides, while TiO2 enrichment results in a high identification number of 185 
mono-p-peptides. This relative lack of multi-p-peptide enrichment from TiO2 has been 186 
attributed to the dissociation difficulty and thus incomplete elution of multi-p-peptides 187 
[14].  188 
1.5 Scope for improvement  189 
Bioinformatic assessment of the available data indicates that current strategies have not 190 
yet captured all predicted phosphosites, so there is still scope for further improvements 191 
[15]. Protein phosphorylation analysis primarily identifies O-phosphorylated amino 192 
acids, where phosphate binds to the hydroxyl moiety in the γ-group, specifically: pSer, 193 
pThr and pTyr, termed the “canonical” phosphorylation sites. The relative abundance of 194 
these sites within biological samples is typically pSer>PThr>pTyr [2].  195 
To ensure comprehensive analysis of biologically relevant phosphorylation events, two 196 
levels of improvements are required – data quantity and data quality. Firstly, the 197 
breadth and frequency of phosphoproteomic studies, whilst increasing, requires 198 
expansion to fill the data gap that will allow a more comprehensive understanding of 199 
phosphoproteome dynamics. To support this, a tutorial is included in section 2 of this 200 
manuscript. This is designed to aid experimental design, preparation, and execution for 201 
new researchers in the field, whilst also providing a reference guide for their own 202 
investigations based on the latest developments in the field described later. Secondly, 203 
the data quality gathered from these studies must be improved; to provide better 204 
quality phosphosite identifications/localizations during proteoform identification from 205 
MS data [16]. This review focuses on improving data quality by reducing the background 206 
sample noise (non p-peptides) through advanced techniques and materials to optimize 207 




achieved by mitigating non-specific binding, whilst enhancing selectivity (high affinity 209 
towards p-peptides), sensitivity (low starting amounts), robustness (tolerance toward 210 
harsh working conditions), high-throughput (less-time consumption) and reproducibility. 211 
Steps that can be taken to improve the performance of IMAC and MOAC are outlined, 212 
such as working condition optimization, novel carriers or hybrid material synthesis, 213 
along with other new developments. 214 
2. Tutorial for phosphoproteomic analysis-general workflow design 215 
This tutorial aims to provide a ‘how to guide’ for designing a strategy to profile the 216 
phosphoproteome, specifically selecting the most appropriate workflow for a given 217 
sample. The focus is on recent protocols, providing step-by-step descriptions of 218 
procedures, including details of p-peptide enrichment strategy, catalogued in Table 2. 219 
(Table 2). Despite advances, the protocols are generally complex and multi-step, taking 220 
several days to complete – this is exemplified in the study of Mertins et al., 2018 that 221 
describes in depth, parallel processing of the phosphoproteome and proteome using 222 
Ni-NTA IMAC for p-peptide enrichment from human tissue samples [17]. When 223 
considering p-peptide enrichment, improved sensitivity, dynamic range, processing time, 224 
and cost are all practical considerations in workflow adoption. Before beginning 225 
p-peptide analysis, a few key questions should be considered to enable effective 226 
planning and execution. 227 
2.1 Starting with a question 228 
As with all proteomic investigations, it should begin with a biological question. 229 
P-peptides present in a sample can be catalogued post enrichment; so combining 230 
p-peptide enrichment with quantitative proteomics enables sample comparison. This 231 
generates relative abundance data and a discovery type proteomics dataset. The new 232 
user should be aware that this dataset will typically be a list of p-peptides and their 233 
associated proteins, likely to contain information on several thousand phosphorylation 234 




well-defined investigation this can make the data analysis challenging. It is thus 236 
advisable to define simple and disprovable null hypotheses, then use bioinformatics 237 
resources (section 2.9) to visualise the data and infer biological significance. Once 238 
identified, a p-peptide may be identified to be altered in amount between samples. They 239 
may reflect an increase or decrease in phosphorylation, but may simply reflect altered 240 
protein abundance. Be aware that p-peptide enrichment is accompanied by a loss of 241 
information about the non-phosphorylated proteome component, so studies that 242 
combine proteomic and phosphoproteomic datasets with a high overlap between 243 
protein and phosphoprotein quantifications can be helpful here. A key benefit is 244 
normalization of phosphorylation, which can help account for protein abundance 245 
differences [18].  246 
2.2 Experimental/process design 247 
As with other proteomic analyses, experimental design is key, particularly the inclusion 248 
of experimental replicates. It is typical to include 2 or 3 experimental replicates for 249 
proteomic analysis, but it has been noted that overlap between replicates of the 250 
p-peptide enrichment same method can require 4-5 replicates to approach asymptotical 251 
gains in downstream MS analysis [19]. P-peptides typically only make up a small 252 
proportion of total proteomic sample, so enrichment strategies enable and improve 253 
detection. As discussed, be aware that different enrichment strategies can produce a 254 
bias towards p-peptides that contain a single, or multiple, phosphorylation sites and can 255 
therefore create bias or blind-spots in the data. Determining the full range of 256 
phosphoproteins in a sample requires testing and combining of a range of 257 
complementary enrichment protocols.  258 
2.3 Planning 259 
With these questions considered, here are a few rules of thumb that will assist practical 260 
planning and execution of a phosphoproteome investigation. In terms of ‘how long will it 261 




associated technical challenges; however, a preliminary experimental run to the final 263 
data analysis stage will provide a clear estimate of the minimum requirements. Breaking 264 
this preliminary investigation into the following stages can help track progress towards 265 
the final experimental procedure: Extraction; Protein digestion; Peptide fractionation; 266 
Enrichment; Mass Spectrometry and Data Analysis [11]. A typical phosphoproteomic 267 
experiment can take several days work to prepare samples and the amount of 268 
LC-MS/MS time is dependent on the choice of p-peptide enrichment strategy, the use of 269 
sample fractionation (see sections 2.6, 2.7). The choice of quantitative proteomic 270 
analysis method influences MS run time, see section 2.8 [20].  271 
2.4 Extraction  272 
The first test to perform is absolute protein quantification from extraction. A trial of this 273 
is advisable even if the ‘best’ procedure for the organism/biological system has already 274 
been identified.  275 
(1) Lysis. Chemical or physical lysis methods can effectively fracture cells, these can 276 
include one or a combination of sonication, liquid nitrogen grinding, bead-beating, or 277 
boiling in surfactant. Some cell types pose specific technical challenges, for which 278 
customised protocols are often available, for example for plant tissues [21]. Samples can 279 
be degraded rapidly at room temperature, so all treatment processes should be 280 
performed on ice. Protease and phosphatase inhibitors are critical for preventing protein 281 
and phosphorylation loss, so these must be included in the lysis buffer [22]. 282 
Phosphate-rich nucleic acids reduce sample quality, so inclusion of nucleases such as 283 
benzonase is beneficial [8].  284 
(2) Contaminants. Be aware of potential contaminants: for example - phospholipids, 285 
photosynthetic pigments, and secondary metabolites in plant tissues produce 286 
interference that increases the sample complexity, reducing efficiency and specificity of 287 
p-peptide enrichment [21]. Sample clean-up is therefore important for improving the 288 




equipment. As a general clean-up consideration, p-peptide enriched samples must 290 
ultimately be compatible with the downstream LC-MS/MS analysis ie. free of salts and 291 
detergents [4]. Total protein can be precipitated using acetone, acetonitrile (ACN) [5], or 292 
methanol/chloroform [8] for 2 h or overnight at -20 °C 293 
(3) How much protein? In general, a larger amount of protein will assist in the detection 294 
of very low abundance p-peptides, and provide more flexibility in the enrichment 295 
process. Typical starting amounts are 0.1 - 5 mg total protein for enrichment [23], but 296 
protocols have been developed to enrich for sub-femtomole level p-peptides from cell 297 
line and human tissue samples where samples are amounts are limited. A protocol 298 
applicable to picograms of starting material, is that applied to human leukocyte antigen 299 
class I p-peptides [24]. Protein concentration can be determined using traditional 300 
protein assays, for example, the Bicinchoninic Acid assay which can be applied to 301 
analysis of either proteins or peptides, as required by the user [17]. Note that not all 302 
traditional protein assay reagents are compatible with common interferences such as 303 
detergents and buffer components used in sample preparation for phosphoproteomic 304 
analysis.  305 
(4) Quality at a glance. Evaluation of protein sample quality, amount and complexity can 306 
be simply performed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis: 1D 307 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 2D gel 308 
electrophoresis. This also provides a simple one step sample clean up and fractionation 309 
process for GeLC-MS, which can form a component of the SILAC quantitative proteomic 310 
workflow. 311 
2.5 Protein digestion 312 
(1) Proteolytic enzymes: Proteins are subject to enzymatic digestion using enzymes - 313 
typically trypsin, Lys-C, Glu-C or Lys-N. Trypsin, alone or in combination with Lys-C, is the 314 




enzyme for proteomic and phosphoproteomic analysis, due to its high proteolytic 316 
activity and cleavage specificity C terminal to lysine and arginine. Tryptic (or Lys-C plus 317 
tryptic) peptides possess m/z values and ionisation characteristics that are well suited to 318 
LC-MS/MS identification.  319 
In some cases, digestion with trypsin can be incomplete, particularly for tightly folded 320 
proteins. The presence of a phosphorylation site can also result in missed cleavage, 321 
which impact quantitative accuracy. Use of sequential digestion protocol using Lys-C, 322 
prior to trypsin, results in fewer missed cleavages [25]. Lys-C and Arg-C can also be used 323 
in combination to generate ‘tryptic’ peptides, but this is not in routine use. It is 324 
interesting to note, that our survey of novel materials (sections 3.2, 3.3), found that of 325 
51 studies employed trypsin or Lys-C, trypsin for testing p-peptide enrichment using 326 
novel enrichment formats. P-peptide discovery, is currently centred on tryptic peptides, 327 
may also be enhanced by the use of alternative proteases. An optimized, robust protocol 328 
suitable for proteolytic digestion by alternative enzymes to trypsin, namely 329 
chymotrypsin, Lys-C, Lys-N, Asp-N, Glu-C or Arg-C has been established [25]. The key 330 
benefits generation of p-peptides with different physico-chemical properties to tryptic 331 
peptides, results in improves coverage (detectability) of the proteome and 332 
phosphoproteome [26]. Sequential enzyme digests, combined with p-peptide 333 
enrichment increase p-peptide coverage, for example Glu-C in combination with trypsin 334 
[27]. There are clear benefits to using alternatives to tryptic digestion.  335 
(2) Efficiency of proteolytic digestion: Strategies to assess proteolytic digestion efficiency 336 
include use of ‘spike’ internal standards and isotope dilution techniques [28, 29]. This is 337 
important because bottom-up proteomics relies on the efficiency and reproducibility of 338 
protein enzymatic digestion. The presence of missed cleavages and nonspecific 339 
cleavages are important sources of variation in protein quantitation. It is important to 340 
note here that phosphorylation of amino acid residues close to trypsin cleavage sites can 341 




sequence context specific [31]. For example, the presence of proline hinders proteolytic 343 
cleavage. A novel enzyme, EndoPro, a proline directed protease that cleaves with high C-344 
terminal site of proline and alanine residues, with a broad pH range of activity mitigates 345 
this limitation of trypsin. EndoPro, unlike trypsin, has an added advantage of being able 346 
to cleave in the presence of a neighbouring phosphorylation site [32]. As such this 347 
enzyme represents a valuable addition to the protease ‘toolkit’ for p-peptide enrichment 348 
workflows. 349 
(3) Modes of proteolytic digestion: This sample processing step can be performed in gel, 350 
in solution or alternatively using filter assisted sample preparation (FASP). In gel and 351 
FASP strategies offer the advantage of sample ‘clean up’ during the digestion protocol. 352 
As an example, FASP has been applied for removal of nucleic acids, phospholipids, 353 
photosynthetic pigments, and secondary metabolites from plant tissues as part of the 354 
universal plant phosphoproteomic workflow [21].  355 
(4) Sample clean up: typically performed at the peptide level, both before and after 356 
p-peptide enrichment, to ensure compatibility with MS analyses. Materials such as C18, 357 
graphite carbon and Hexagonal boron nitride are typically used for solid phase 358 
extraction (SPE) for enriching and desalting of peptides with a range of physicochemical 359 
properties. The performance of boron nitride is comparable to combined C18 and 360 
graphite carbon material, as discussed in a review article discussing protocols used for 361 
sample clean up procedures in proteomics [33].  362 
2.6 Fractionation 363 
Sample complexity can be reduced by high performance liquid chromatography (HPLC) 364 
separation at the peptide level [14, 15]. Peptides derived from complex samples 365 
particularly benefit from an independent ie ‘offline’ pre-fractionation step, in addition to 366 
the fractionation ‘online’ (also termed ‘hyphenated’) or ‘coupled’ to LC-MS/MS. The 367 




reverse phase (RP)-HPLC employed in LC-MS/MS to ensure that different 369 
physico-chemical properties are exploited for maximum reduction in sample complexity. 370 
Since reversed phase ‘online’ fractionation is based on hydrophobicity, ‘offline’ 371 
fractionation typically uses charge based separation. In terms of ‘best practice’, a 372 
comparison of strong cation exchange (SCX), electrostatic repulsion hydrophilic 373 
interaction chromatography (ERLIC), and solution isoelectric focusing (sIEF) fractionation 374 
upstream of RP-LC-MS/MS analysis (in terms of identified p-peptide numbers) indicated 375 
SCX-LC-MS/MS > sIEF-LC/MS-MS > ERLIC-LC-MS/MS. There was partial overlap in the 376 
type of p-peptide and phosphosites, identified between methods, but also populations 377 
of p-peptides unique to each fractionation type, indicating complementarity [9]. 378 
Chromatographic materials are available in both column (ml min-1 flow rates) and 379 
tip-based format. Dehghani and co-authors evaluated different fractionation strategies 380 
following TiO2 treatment for p-peptide enrichment, including column-based SCX (the 381 
most commonly used SCX approach), pipette tip-based SCX, concatenated high-pH 382 
reversed-phase (basic-RP), and column-based strong anion exchange (SAX). SCX 383 
methods produced higher observations of p-peptides than either basic-RP or SAX; with 384 
SAX showing a greatly reduced number of phosphosite relative to basic-RP [8]. 385 
Fractionation of p-peptides using pipette tip-based columns leads to similar results as 386 
the common approach using liquid chromatography-based methods [8]. The number of 387 
observed p-peptides from the pipette tip-based SCX were comparable with the number 388 
detected using the column-SCX method, but with the advantage of greatly reduced cost, 389 
time and complexity. Basic-RP is popular due to high peak capacity, reproducible 390 
retention times, and orthogonality to low-pH RP based separation, and is applied for 391 
peptide fractionation either pre or post p-peptide enrichment [17, 21].  392 
‘Offline’ fractionation reduces sample complexity, which is always beneficial; but it has 393 
limitations. Fractionation requires higher amounts of starting material, and increasing 394 




quality of the data, at the expense of a linear increase in MS time and associated costs. 396 
While offline fractionation is designed to achieve higher depth of p-peptide coverage ie 397 
more identifications, samples can be run without a pre-fractionation step as a ‘single 398 
shot’. It should be noted that in this case that the number of p-peptides may exceed the 399 
analytical capacity (typically 1 microgram) of the nano flow RP-HPLC column [8].Trial 400 
runs of unfractionated sample can typically be trialled against 5 selected fractions, to 401 
determine the optimal output for the investigation and identify fractions that provide 402 
the highest number of peptides (the typical peptide amount is approximately 1 μg). 403 
There is a great diversity of ‘offline’ fractionation types and formats, and so it is 404 
recommended that the best methods should be determined empirically to meet 405 
requirements of the study. 406 
Recent developments have enabled detection and profiling of p-peptides containing 407 
histidine (pHis) and other non-canonical phospho amino acids (aspartate (Asp), arginine 408 
(Arg), lysine (Lys), glutamate (Glu), cysteine (Cys)) based on selection of buffers that 409 
maintain the acid labile phosphate. This approach, termed UPAX leads to unbiased 410 
p-peptide enrichment strategy for both canonical and non-canonical phosphorylated 411 
peptides using SAX chromatography at near-neutral pH (pH 6.8). This study enabled 412 
identification of 1300 His, Arg, Lys, Asp, Glu and Cys phosphorylation sites [34]. The data 413 
clearly indicated that pHis, Lys and Arg are present at a similar order to the numbers 414 
observed for pTyr under basal conditions in human HeLa cell extracts [34]. 415 
2.7 P-peptide enrichment 416 
A range of methods are available, of which IMAC, MOAC, PolyMAC and antibody-based 417 
enrichment of PTyr are well established (Fig. 1b). The mode of operation is sequential 418 
steps: peptide capture (including non-specific binding of non p-peptides), washing to 419 
remove non p-peptides and elution of p-peptides (Fig. 1c).  420 
Methods for which there are step-by-step guides, with detailed protocols and 421 




material and p-peptide data generated (Table 1). The protocol of Mertins et al., [17], in 423 
common with the other protocols lists, first resuspends proteolytically derived, tryptic 424 
peptides in buffer containing 0.1% trifluoroacetic acid at pH 2, to ensure that the 425 
carboxyl groups of the peptide C termini, glutamic and aspartic acid are protonated. The 426 
negatively charged p-peptides preferentially bind to the resin relative to non p-peptides. 427 
As a general note, performing a test run to establish p-peptide recovery aids 428 
establishment of a method and ensures efficient use of expensive reagents and samples.  429 
The ideal method would efficiently capture all p-peptides in the sample and result in full 430 
recovery of p-peptides from the capture material. New developments in the area are 431 
summarised in Fig 1d and described in detail in section 3. 432 
2.8 Mass Spectrometry 433 
(1) A typical LC-MS/MS run time employs 1-3 hours gradients of RP-HPLC operating at 434 
nanoflow rates. A typical sample loading is up to 1 microgram of p-peptide on column. 435 
Evaluating sample loss during the different steps in the sample preparation workflow, 436 
allows the amount of starting materials to be estimated to ensure sufficient p-peptide is 437 
available for analysis. 438 
(2) The physical run time of the MS analysis varies, dependent on how complex the 439 
sample is, and the exact running parameters used on the HPLC and MS, as has been 440 
reviewed in depth [11]. In general, label free quantification methods, comparing MS 441 
data between consecutive LC-MS/MS analysis of samples and replicates require more 442 
MS time than methods using multiplex sample analysis eg SILAC (2-3 plex), isobaric 443 
chemical labeling (4, 8 plex iTRAQ, up to 11 plex TMT).  The choice of quantitative 444 
phosphoproteomic method also impacts run time, quantitative precision and accuracy 445 




2.9 MS Data Analysis 447 
It is important to ensure that the correct proteomic database is available for database 448 
searching. Database files are typically in FASTA format although this is dependent on the 449 
search engine being used, and long-form database formats can provide additional 450 
information during analysis. These databases can be readily obtained from SwissProt 451 
and NCBI public data repositories for organisms with genome sequence data. Be aware, 452 
if the genome for the organism has not been sequenced and annotated, or if the study is 453 
a metaproteomic analysis, these are both considered advanced investigations with much 454 
more challenging data analysis [35], particularly at the level of PTM [36]. It is advisable 455 
to not perform a first-time phosphoproteomic analysis on these systems unless 456 
advanced bioinformatic support and researcher expertise in phosphoproteomics is 457 
available. 458 
A range of computational tools and MS data analysis for p-peptide and site localisation 459 
are available, which are well catalogued and described, alongside proteomic data 460 
analysis pipelines by Paul et al., 2019 [37]. Locard-Paulet et al [38] compared 22 461 
pipelines for bottom-up phosphoproteomics analysis involving data base search tools 462 
(MaxQuant, Proteome Discoverer, PeptideShaker), search engines (Andromeda, Comet, 463 
Mascot, MS Amanda, SequestHT, and X!Tandem), and localization scoring algorithms 464 
(delta score, D-score, PTM-score, phosphoRS, and Ascore) for a defined dataset. 465 
Variability in outcomes led to a recommendation to report search and 466 
phospho-localization parameters when publishing datasets, so as to enable accurate 467 
integration of phosphosite assignment from different analysis pipelines. Further 468 
processing for the data, using tools such as the open-access biological pathway 469 
knowledge base Reactome [39] becomes quite specific to the study in question; so 470 
practicing the bioinformatics analysis using a pre-generated dataset from a similar 471 




3. Strategies for improving p-peptide enrichment 473 
This section highlights and discusses the recent improvements to the enrichment 474 
process. It broadly divides these into improvements that focus on the buffers, the 475 
separation matrix materials, and methods to provide enhanced coverage of the 476 
p-proteome. 477 
3.1 Buffers 478 
3.1.1 pH 479 
As the interactions between p-peptides and IMAC/MOAC materials are Lewis acid-base 480 
reactions, pH is a major consideration during the enrichment process. Non-specific 481 
binding of acidic peptides containing aspartate (pI=2.9) and glutamate (pI=3.0) emerged 482 
as a major limitation, as reviewed by Fila and Honys, 2012 [22]. This is caused by the 483 
affinity between the carboxylate moiety on the amino acid γ-group and metal ions 484 
materials emulating the phosphate to metal ion affinity. This non-specific binding can be 485 
reduced by decreasing the pH of loading buffer below the pI of aspartate or glutamate 486 
to remove the negative of charge of acidic residues by protonation. The pH of loading 487 
buffer is a critical consideration, since the number of bound p-peptides will also 488 
decrease at low pH due to protonation of phosphate (pKa=2.12) groups. Thus, 489 
co-purification of acidic peptides and p-peptides is unavoidable [22]. Contamination with 490 
peptides rich in acidic residues is more pronounced in complex biological samples, and 491 
negatively impacts the enrichment efficiency. To prevent the non-specific binding issues 492 
caused by acidic peptides, O-methyl esterification can be performed on the acidic 493 
residues; however, the additional steps can result in sample loss through both increased 494 
sample interaction and side reactions [14].  495 
The choice of elution buffer and elution method can have a significant impact. A number 496 
of strategies employ a step-wise pH or buffer elution methodology, some recent 497 




bis-Tris propane (pH 11.3); two-step elution (ammonium hydroxide (NH4OH) and bis-Tris 499 
propane) [15]; 100 mM ammonium bicarbonate (NH4HCO3) (pH 9.2-11.3 step gradient 500 
and pH adjust by ammonia) [16]; and 10 mM ethylenediaminetetraacetic acid (EDTA) 501 
buffers [17]. Alternatively, highly acidic solutions such as 1% v/v trifluoroacetic acid 502 
(TFA), pH1.0 [18] have also been employed. The reader is referred to the review article 503 
by Fila and Honys for more theoretical information and a review of traditional IMAC and 504 
MOAC techniques, with a specific focus on optimization of elution buffers for IMAC [22]. 505 
3.1.2 Optimized buffers for IMAC elution 506 
Obtaining an ideal elution buffer is imperative for efficiently eluting the bound 507 
p-peptides from IMAC resins, and therefore high p-peptide recovery. The ideal elution 508 
buffer should have good elution efficiency (ideally 100%) and should be compatible with 509 
subsequent MS analysis. IMAC-bound p-peptides can be eluted by phosphate containing 510 
buffers 10 mM EDTA, or ammonium hydroxide (pH 10-11) [40]. Optimal ratios of sample 511 
to IMAC material, and the most efficient eluent solution, should be determined 512 
empirically on a case by case basis, depending on small- or large- scale starting 513 
materials.  514 
3.1.3 Optimized MOAC buffers 515 
The chemisorption of p-peptides and non-specific binding of acidic peptides is 516 
problematic for MOAC using TiO2. Previous efforts have been employed to investigate 517 
the optimized working conditions for buffers. For instance, the application of additive 518 
acids as non-p-peptide inhibitors to solve the strong surface Lewis acidity issues of metal 519 
oxides. Generally, the order of binding interactions with metal oxides of TiO2 is: 520 
phosphate group > organic acid > carboxyl group [41]. Therefore, the addition of organic 521 
acids competes for binding sites with acidic residues, to reduce non-specific binding and 522 
thus enhance TiO2 and ZrO2 p-peptide enrichment specificity [41]. A number of 523 
‘non-phosphopeptide- excluding compounds’ have been identified, including 2,5-DHB 524 




to be preferable because of better compatibility with LC-MS/MS than 2,5-DHB [42]. 526 
Mono p-peptide enrichment is less efficient through using 1M citric acid, which is 527 
possibly caused by its similar binding to TiO2 beads as mono p-peptides [41]. In general, 528 
the effect of added acids as non-phospho peptides inhibitors has been demonstrated to 529 
vary with the utilized materials [43]. For instance, TiO2, ZrO2, In2O3 and Fe2O3 showed 530 
significantly improved performance for p-peptides enrichment with the addition of lactic 531 
acid in the loading buffer. In contrast, NiO and SnO2 exhibited reduced specificity for 532 
p-peptide binding in the presence of lactic acid [43]. 533 
Furthermore, researchers noted that peptides containing multiple glutamine and 534 
asparagine residues (named N/Q-rich peptides) predominantly co-enriched with 535 
p-peptides by IMAC or TiO2, as determined by examination of amino acids distribution 536 
patterns [44, 45]. Notably, the portions of poly-N/Q peptides of non-p-peptides varied 537 
depending on the examined species. Amide containing compounds as buffer modifiers 538 
mitigate N/Q-rich peptides for efficient TiO2 enrichment. As a result, addition of 125 mM 539 
asparagine and glutamine amino acid amides in the wash buffer (70% ACN, 3% TFA) and 540 
an optimum peptide/TiO2 ratio (408 µg/mg) [45] resulted in a 30% increase in detected 541 
p-peptides number, as well as a 5-fold decrease in the intensity of non-p-peptides, 542 
without an obvious change in p-peptides intensities [45]. Thus, modifications to buffers 543 
are of proven value in optimization of p-peptide protocols. 544 
3.2 P-peptide enrichment – optimization strategies 545 
3.2.1 Optimization of IMAC materials 546 
3.2.1.1 Development of novel IMAC materials 547 
Novel IMAC formats with high valence metal cation-IMAC such as Ti4+, Zr4+ [46], Nb5+ [47, 548 
48], Hf4+ [49], or Sn4+ [50] have attracted increasing interest due to their high enrichment 549 
efficiency, reusability and relative low detection limit relative to the traditionally used 550 




efficiency systematically, by coating Fe3O4@PDA (polydopamine) microspheres with 552 
eight different metal ions. Nb5+, Ti4+and Zr4+ showed better selectivity, while Nb5+, Ti4+ 553 
and Ce4+ displayed higher sensitivity than the other tested materials on tryptic digests of 554 
nonfat milk or β-casein [46]. Thus, Sn4+ or Nb5+ were proposed to show similar 555 
performance as Ti4+ in terms of higher selectivity and enhanced sensitivity [46]. This 556 
agrees well with the previous finding that high valence metal cations present better 557 
p-peptide binding capacity due to a higher coordination number. In addition, the 558 
synthesis of binary metal ions shows promise. For instance, the novel synthesized 559 
Fe3O4@PDA-Ti/Nb outperforms either single usage or physical mixture format [48]. 560 
Notably, it is still unclear how applicable these findings apply to true complex biological 561 
samples, as they were tested on casein protein standards, which are arguably not 562 
representative of all p-peptide types in phosphoproteomic samples.  563 
3.2.1.2 Development of chelating ligands for metal cations immobilization 564 
In addition to testing higher valence metal ions, the method of IMAC can also be 565 
modified by testing different affinity substrate supports and alternative chelating ligands. 566 
Acidic chelating ligands (iminodiacetic acid (IDA), nitrilotriacetic acid (NTA) have mostly 567 
been applied to date. To improve on drawbacks: such as limited specificity and metal 568 
ions loss issues of IDA and NTA; a phosphate group was introduced to immobilize Ti4+ or 569 
Zr4+, but the time-consuming nature of this process limits its more general application 570 
(metal ion immobilization, enrichment, elution) and limits the absorbent surface area. 571 
Moreover, to enhance the poor selectivity caused by the presence of carboxyl groups of 572 
IDA or NTA, alternate IMAC affinity substrates have been rapidly developed (see 573 
supporting Table S1B for representative formats).  574 
 575 
Developments include: 576 
(1) The application of graphene with large surface areas and the introduction of a phytic 577 




metal ion coordination ability resulting in more affinity sites for IMAC. Moreover, the 579 
excellent hydrophilicity of PA can further reduce non-specific adsorption [51]. Example 580 
formats include MagG@PEI@PA-Ti4+ [51] (Fig 2a) which yielded a total of 574 p-peptides 581 
from 341 phosphoproteins were detected from 200 μg of HeLa cells using MagG@ 582 
@PA-Ti4+ [51]. The inclusion of polyethyleneimine (PEI), a water soluble polymer 583 
conferred HILIC properties to the IMAC material, enabling binding of N glycopeptides in 584 
addition to p-peptides (see section 3.3.8). 585 
(2) Recently, the employment of guanidyl group to modify superparamagnetic SiO2 586 
spheres significantly enhance the p-peptide capture specificity, e.g. PAMA-Arg 587 
(polydopamine/poly(2-Aminoethyl methacrylate hydrochloride)/arginine) nanospheres. 588 
With abundant guanidyl and amino groups on these brushes, the newly synthesized 589 
nanospheres exhibited superior selectivity, sensitivity (10-12 M) and prominent 590 
recyclability (signal intensity of multi-p-peptide remains 80% after 5 cycle usage) for 591 
β-casein as well as biological samples (egg white, non-fat milk and rat brain lysate) [52].  592 
(3) PDA benefits from the abundant amine and catechol hydroxyl groups it contains, 593 
enabling the coating on diverse surface of organic and inorganic materials through the 594 
self-polymerization of dopamine under a weakly alkaline environment [53], as shown in 595 
Fig 2a-2b. For instance, with high content of Ti4+ chelated by PDA, Ti4+@PDA@GA was 596 
proven to be highly efficient for enriching p-peptides from a mixture of model 597 
phosphoproteins (β-casein) and non-phosphoprotein (bovine serum albumin, BSA), milk 598 
and spiked human serum [53], as shown in Fig 2b.  599 
(4) Finally, researchers have pursued development of an easy-to-conduct process to 600 
cope with limited surface area, time consumption cost, and weak coordination. 601 
Compared to the conventional IMAC technique, various micro/nanoparticles including 602 
magnetic core-mesoporous shell variants, mesoporous SiO2 supported nanocomposites 603 
show promise [54]. On one hand, the synthesized novel sorbents mostly exhibit 604 
excellent performances for p-peptide enrichment due to the intrinsic and robust 605 




p-peptides. Examples include the development of Fe3O4@mSiO2-Ti4+ [47], 607 
magG@PDA-Hf4+ [49] as indicated in Fig 2c, magG@PDA-Sn4+ [50], and 608 
Fe3O4@SiO2@GMA@IDA@Ti4+ [55], all of which benefit from the utilization of magnetic 609 
microspheres. On the other hand, the loss of magnetization with the increased number 610 
of shells is not negligible, particularly for those nanostructures using magnetic 611 
core-shells. In addition, interference may be caused by interactions between the 612 
magnetic core and e.g. an acidic Ti4+ attachment medium [56]. The creation of 613 
MagSiO2@SiO2@PDA@Ti(IV) [56] mitigates this since the porous SiO2 shell layer was 614 
introduced to protect magnetic core from the acidic medium of Ti4+ attachment. With 615 
stronger and stable magnetic responsiveness, these microspheres indicate good 616 
(detection limit of 50 fmol/mL) and stable reusability performance on five successive 617 
enrichment cycles for enriching p-peptides from the tested samples of tryptic digests of 618 
a β-casein/BSA mixture and human serum. Although, the drawback is that the synthesis 619 
of these solid supports has been shown to be time-consuming due to the separate 620 
covalent attachment of the functional groups into the sorbent structure, as well as a 621 
tedious post-derivatization process.  622 
 623 
Efforts are developing toward the “green” synthesis of materials, which is 624 
easy-to-conduct and show excellent enrichment performance: sensitivity, selectivity and 625 
robustness.  626 
3.2.2 Optimization of MOAC 627 
One of the advantages of MOAC over IMAC is that the oxide form of the ion is more 628 
stable than the metal ion form and has better tolerance to salts, detergents and solvents, 629 
under operational pHs and temperatures, as well as good sensitivity and selectivity [57]. 630 
Intensive studies have been performed for p-peptide enrichment using metal oxides 631 
such as listed in supporting Table S2. Key factors affecting MOAC binding performance 632 




isoelectric point (IEP) and magnetic properties, and the presence of additives [43, 58, 59]. 634 
Among these, IEP is considered to be the most critical parameter for the enrichment 635 
performance of affinity materials. The widely used TiO2, ZrO2 and In2O3 have an IEP 636 
around of 6, which has been determined to be optimal for p-peptide enrichment [43]. 637 
TiO2 -based approaches have been widely applied for p-peptide purification, due to 638 
higher selectivity and specificity (in terms of the number of identified p-peptides based on 639 
peptide counts) as well as robustness, amphoteric ion-exchange characteristics, and 640 
tolerance towards many regents (stable in wide pH ranges) [43, 57]. 641 
3.2.2.1 Novel Synthesized Metal Oxides 642 
Commercially available TiO2 is the most commonly used material for MOAC, but there 643 
are a number of new metal oxides that show promise. Such materials, include 644 
molybdenum (VI) oxide (MoO3) nanocomposites coated on graphene oxide (MoO3/GO) 645 
[60], In2O3 [43], and 1,3,5-benzenetricarboxylic acid (H3btc) [61]. These oxides can show 646 
greatly enhanced sensitivity to p-peptides, for example H3btc grafted on the PDA-coated 647 
Fe3O4 (Fe3O4@PDA@Er(btc)) achieved a detection limit of 20 amol/μL, and high 648 
efficiency when tested in human serum, making it a very promising candidate for 649 
phosphoproteome research [61].  650 
3.2.2.2 Developments for MOAC -novel ligand supports 651 
As with IMAC, specificity is still a bottleneck for MOAC enrichment, but improvements to 652 
the supporting sorbents can help to address this. A variety of micro/nanostructures have 653 
been developed aimed at high sensitivity and selectivity towards p-peptides. Further 654 
details are available in supporting Table S2. Whilst issues arising from the high Lewis acid 655 
strength of metal oxides can be addressed by application of diverse acids in loading and 656 
washing buffer; the mono p-peptide affinity and “shadow effects” in MOAC may be 657 
caused by the small and deep pores of metal oxide/s. These small crystallites can hinder 658 




using synthesized yolk-shell magnetic materials, as observed in Fe3O4@H-fTiO2 (Fig. 3a) 660 
and Fe3O4@H-TiO2@f-NiO [62, 63]. 661 
Supporting composites with high surface area have attracted interest due to their 662 
potential for greatly enhancing the loading capacity, which contributes improved 663 
p-peptide enrichment. Examples include coordination with GO, for 664 
GO-trimethyl-2-methacroyloxyethyl ammonium chloride-titania monolithic column 665 
(GO-META-TiO2) [64] and F-TiO2-GO (Fig. 3b) [65]. Supporting resins with high surface 666 
area also result in higher p-peptides coverage, favour the isolation of large p-peptides, 667 
and lead to the detection of high number p-peptides with higher abundance. For 668 
instance, the application of graphitized carbon black (mGCB@TiO2) led to 48% 669 
enrichment coverage (p-peptides / total peptides), elution of 10% of the common 670 
p-peptides and favours detection of p-peptide >3 KDa, while commercial spin column 671 
resulted in the detection of 40% enrichment coverage but only 1% high abundant 672 
p-peptides, with p-peptide <2.5 KDa [66]. Another example is Fe3O4@H-fTiO2 (yolk-shell 673 
magnetic nanoparticles modified with macro/mesoporous TiO2 nanosheets). Compared 674 
to hollow magnetic mesoporous TiO2 (Fe3O4@H-mTiO2), the high p-peptide enrichment 675 
performance of hollow magnetic macro/mesoporous TiO2 nanoparticles (Fe3O4@H-fTiO2) 676 
is attributed to the high surface area and large pore volume owed by the porous 677 
nanostructure and large hollow space [62]. 678 
Improvements towards reducing the non-specific adsorption of acidic and other 679 
peptides during MOAC have been developed. One practically demonstrated example is 680 
the introduction of a functional group with high enrichment affinity toward p-peptides 681 
or interface to the metal oxide to eliminate the non-phosphorylated peptides. For 682 
instance, the introduction of a guanidyl-functionalized group into TiO2 (F-TiO2-GO) 683 
improved p-peptide binding for TiO2 [65]. Another example is integration of a hydrophilic 684 
fructose-1,6- diphosphate (FDP), which acts as a modifier to regulate the surface 685 




(DZMOF) that inhibited non-specific binding from other peptides [67]. It is proposed to 687 
benefit from the strong interaction between FDP and metal sites of DZMOF that 688 
produces a high anti-interference performance for eliminating the non-phosphorylated 689 
peptides [67]. This modification is thus an effective development for the enrichment of 690 
p-peptides [67]. The negatively charged surface (pH 5-11) of nanocomposites 691 
PI-FexOy-ZrO2 was inferred to function (repulsive effect) to reduce the non-specific 692 
adsorption of acidic peptides [68]. Through co-doping of magnetic FexOy partial and ZrO2 693 
nanoparticles on polyimide, PI-FexOy-ZrO2 composite indicate uniform mesopore size of 694 
ca. 3.9 nm, which blocks the entrance of protein but allowing the penetrance of 695 
p-peptides into pore channels, efficiently reducing non-specific protein adsorption [68]. 696 
PI-FexOy-ZrO2 exhibit better adsorption capacities towards the tryptic p-peptides from 697 
human serum or BSA/β-casein mixture: p-peptide signal intensity was increased by 698 
tenfold and a large number of p-peptides detected [68]. In summary, research in this 699 
area has provided significant gains in performance. 700 
For ease of flexibility in operation and application, efforts have been directed to provide 701 
materials with wide pH range or elution conditions, highly acidic/alkaline or hydrophobic 702 
conditions tolerance and more efficient p-peptide capture. An example format is 703 
CIM-OH-TiO2 column (CIMac™ hydroxyl-based analytical column with immobilized TiO2 704 
nanoparticles), which offers higher contact area with p-peptides than is achieved using 705 
the traditional macroporous format [69]. Magnetic nanocomposites are attracting 706 
interest from the proteomics researchers; a detailed analysis of their benefits and 707 
limitations is provided by an overview article by Batalha et al [70]. 708 
3.2.3 Physical configuration considerations 709 
A number of different configurations exist for operating MOAC-TiO2, these include spin 710 
column, analytical column, miniaturized column, batch format, nanoparticles, magnetic 711 
beads and p-peptide-affinity MALDI (matrix-assisted laser desorption ionization) plates. 712 




manual operation is needed during the enrichment procedure. This is very 714 
labour-intensive, and thus less time efficient. Spin columns are easier to operate than 715 
the manual column format, but are limited by both volume and column clogging issues. 716 
Magnetic format material is generally superior, because of the practical ease of 717 
magnetic separation, the avoidance of packing columns for material preparation, and 718 
much simpler manipulations for the loading, washing, and removal steps. Where 719 
applicable, nanoparticles are more effective than micro-particles due to their higher 720 
surface area. As an example, ZrO2 packaged tips were shown to be superior to TiO2 for 721 
mono p-peptide enrichment; however, these differences were found to be negligible 722 
once the material size was comparable [43].  723 
3.2.4 Optimization of composition and structure of carriers and chelates 724 
Efforts have focussed on exploring the diverse composition and structure of carriers and 725 
chelates of the support resins. These include different formats such as magnetic beads, 726 
MALDI plates, columns, tips and gels. In addition, researchers have improved and 727 
optimized diverse reaction conditions for different materials, for instance, the 728 
application of PDA-grafted hybrid magnetic particles for Fe3O4@PDA-Ti, Fe3O4@PDA-Nb 729 
or Fe3O4@PDA-Ti/Nb [48]. For highly efficient enrichment, batch- and tip-based 730 
approaches require further optimization. Developments of new supporting formats are 731 
necessary for enabling high-throughput approaches, due to the multiple manual 732 
handling steps required for these protocols. A few exciting new examples of these 733 
support formats include: the lab-in-syringe mode of Ti4+@PDA@GA (graphene aerogel, 734 
GA)[53]; the TiO2 nanoparticle packed channel array glass microchip [71]; 735 
instrument-free TiO2-modified filter paper-based analytical device [72]; “green 736 
synthesised” Ti4+-IMAC carbonaceous spheres using glucose, vinylphosphonic acid and 737 
water solvent [73] automated p-peptide enrichment and desalting tip set up [74]. All of 738 
these methods are time and cost effective, compared with the commonly used batch 739 




3.2.5 Co-doping of metal oxide/ion with metal oxide 741 
The synthesis of hybrid materials based on the distinct selectivity of metal ions or metal 742 
dioxides to p-peptides is becoming an area of interest; with a typical diagram of the 743 
p-peptide enrichment strategy shown in Fig. 4.  744 
Remarkably, composites containing different metal oxide/ions precursors demonstrated 745 
effective p-peptide enrichment capacity (supporting Table S3, for instance, 746 
TiO2/Bi/Fe/Zr [58], B0.15F0.15TNs [59], and MnFe2O4 MAMSs [75]).  747 
Compared to the commercial available TiO2, the co-doping of metal (ions Bi3+, Fe3+ and 748 
Zr4+) with TiO2 nanocomposite results in an increased surface area, which leads to a 749 
lower detection threshold for casein/BSA, and a higher detection number of p-peptides 750 
(26% more for HeLa cells using TiO2/Bi/Fe/Zr) [58] and phospho-sites (two-fold more for 751 
tissue protein extract from human liver using B0.15F0.15TNs) [59]. Similarly, the combined 752 
usage of ferric and manganous ions as precursors, in the novel synthesized MnFe2O4 753 
MAMSs microspheres, showed a higher selectivity for p-peptides than Fe3O4 754 
nanoparticles or MnOOH nanosheets individually [75]. Similarly, co-fabricating Zr and Ti 755 
simultaneously as a (Zr-Ti)O4 composite [76], or Al2O3 with either La2O3, CeO2, ZrO2 or 756 
TiO2 [77] proved to be superior to the individual metal oxides, demonstrated by their 757 
stronger specificity and higher selectivity for p-peptide enrichment.  758 
Synthesized IMAC/MOAC hybrid materials also provide good adsorption capacity, which 759 
improves p-peptides enrichment capacity. This was demonstrated with the magnetic 760 
nanoparticle Fe3O4@nSiO2@mSiO2/TiO2-Ti4+ (Fig. 4a), where β-casein p-peptide numbers 761 
were six times higher than Fe3O4@TiO2; and more p-peptides were identified from 762 
human serum than IMAC (Fe3O4@nSiO2@mSiO2/Ti4+) or MOAC 763 
(Fe3O4@nSiO2@mSiO2/TiO2) alone, whilst providing equal detection for peptides with 764 
single and multiple phospho-sites [78]. These nanoparticles are constructed from a 765 
magnetic Fe3O4 core, which is stabilized by a supporting nonporous silica layer (@nSiO2). 766 
A mesoporous silica layer (@mSiO2) then provides large surface area, to which metal 767 




3.2.6 Efficient coupling molecules for hybrid composites 769 
Similar to the optimization on supporting ligands for IMAC or MOAC, enhanced 770 
p-peptide enrichment efficiency can be acquired through the incorporation of different 771 
coupling molecules for hybrid composites. These coupling molecules improve trapping 772 
affinity through improved covalence with metal ions, provision of charge-based 773 
selectivity, or provision of a porous binding environment with high surface area. 774 
Examples of these include: (1) DOTA (1,4,7,10-tetraazacyclododecane N, N’, N’’, 775 
N’’’-tetra-acetic acid), which provides enhanced covalently binding with Zr4+. The 776 
resulting TiO2@DOTA-Zr (Fig. 4b) has demonstrated strong p-peptide trapping affinity 777 
[79]. (2) The coordination of polyacrylate (PAA) with Ti/TiO2 presents strongly 778 
hydrophilic carboxyl groups for PAA-Ti/TiO2, which prevents the non-specific binding 779 
from non-p-peptides [80] and resultant good selectivity. (3) Another example is the 780 
employment of TiO2 as inner shell and flowerlike NiO as an outer shell for 781 
Fe3O4@H-TiO2@f-NiO. The porous nanostructure and large hollow space endows it with 782 
a high surface area, large pore volume and a better enrichment performance than 783 
Fe3O4@H-TiO2[63]. (4) In addition, contributions from superparamagnetism and ordered 784 
mesoporous channels of (magnetic) graphene into enhanced p-peptide affinities has 785 
been demonstrated for G@TiO2@mSiO2 [81] (as shown in Fig. 4c) and 786 
magG/PD/(Zr-Ti)O4 [76].  787 
Similar to the novel synthesized particles, the excellent enrichment performances of 788 
hybrid composites is inferred to be: (1) the combined advantages of various materials, 789 
for instance, the dual metal centres of DZMOF containing both inherent Zr-O clusters 790 
and immobilized Zr (IV) contribute greatly to its high selectivity [67]. (2) The increased 791 
surface area and pore volume. (3) The existence of abundant carboxylate groups in the 792 
synthesized materials compared to the single strategy. Disadvantages lie in the limited 793 
surface area and affinity sites caused by the irregular morphology, or single pore 794 




3.2.7 Phosphate-binding molecular tag chromatography (Phos-tag) 796 
The design of Phos-tag is based on the phosphate binding catalytic domain of alkaline 797 
phosphatase. Phos-tag molecules are anchored to a separation gel matrix that peptides 798 
are run through. P -peptide are trapped by the immobilized Phos-tag in the separation 799 
gel, and migrate more slowly than their non-phosphorylated counterparts, allowing 800 
p-peptides and non p-peptides to be separated due to their relative electrophoretic 801 
mobility [82, 83]. Interaction of phospho-sites with the Phos-tag reagent is similar to 802 
IMAC, with application to p-peptides and phosphoproteins [82-84]. Both techniques are 803 
based on the binding between the negative charge of phosphate and positive charge of 804 
ions. P-peptides are captured by the immobilized ions under acidic conditions and eluted 805 
by basic solutions such as ammonium. The major difference between the Phos-tag 806 
workflow and that for IMAC is in the pH aspect. For instance, the working pH for 807 
Phos-tag is alkaline or neutral, while the pH for IMAC is acidic (pH < 3). A benefit of the 808 
Phos-tag approach is the ability to capture both canonical, acid stable phosphorylated 809 
Ser/Thr/Tyr; and non- canonical, acid labile phosphorylation of His/Asp/Lys due to 810 
operation at neutral phosphate. Recently, a small number of p-peptide enrichment 811 
studies have been carried out to improve enrichment efficiency using the Phos-tag 812 
approach under different incubation and elution buffers, such as the exploitation of 813 
Phos-tag-based micropipette-tip format, and the incorporating of two zinc metal ions 814 
into the acrylamide-pendant Zn2+-Phos-tag SDS-PAGE [82, 83]. This application of 815 
Phos-tag strategy suffers from limited separation ability and alkaline buffer instability. 816 
Using the Phos-tag as an additive in SDS-PAGE can also enable differentiation of 817 
phosphorylated and non-phosphorylated forms of a protein, as the electrophoretic 818 
mobility is altered due to the binding of the Phos-tag. This also enables separation of 819 




3.2.8 Polymer-based metal ion affinity capture (PolyMAC) 821 
For PolyMAC (polymer-based metal ion affinity capture) technique, p-peptides chelate 822 
to metal ion-functionalized soluble nanopolymer, and thus isolated in a homogeneous 823 
aqueous environment [86]. In brief, this protocol employed the following steps (1) the 824 
ions (e.g. Ti or Fe) were immobilized on soluble polymers for fast chelation; (2) then, the 825 
PolyMAC and p-peptide complexes were covalently coupled to the solid support (e.g. 826 
agarose beads); (3) finally, gel was washed and p-peptides were eluted by using 827 
ammonium hydroxide solution [86]. Compared to the commonly used solid-phase 828 
extraction method for p-peptide capture of IMAC or MOAC, PolyMAC utilize soluble 829 
functionalized dendrimers for p-peptide binding [86, 87]. Previously, a PolyMAC-Ti 830 
technique has been demonstrated to show superior reproducibility for p-peptides 831 
enrichment than IMAC or TiO2 for cancer samples [11]. Later, PolyMAC enrichment using 832 
Fe demonstrated better selectivity and specificity than Ti, the combined PolyMAC-Ti and 833 
PolyMAC-Fe provided complementary information for B cell phosphoproteomic analyses 834 
[88]. There are also few reports on the use of hydroxyapatite chromatography for 835 
p-peptide enrichment [89]. Although these studies (using Phos-tag, PolyMAC and 836 
hydroxyapatite chromatography) offer some benefits, they have not been widely tested 837 
in complex samples; therefore, their superiorities to IMAC and MOAC at this stage have 838 
not been conclusively demonstrated.  839 
3.3 Improving phosphoproteome coverage 840 
3.3.1 Enhanced multi-p-peptide enrichment 841 
Techniques have been developed for efficient enriching of proteins with high levels of 842 
phosphorylation, specifically peptides containing two or more phosphorylation sites, as 843 
a result of the biological importance of these peptides/proteins [14]. Capturing these 844 
multiple phosphosite peptides is challenging; due to both enrichment material capacity 845 
limits, and the high affinity between enrichment materials and phosphates that result in 846 




interactions between Ti4+ and multiple phosphosite peptides, was seen in 848 
Fe3O4@SiO2-PLP-Ti4+, where low recovery rates of multiple phosphosite p-peptides were 849 
observed [91]. Multiple phosphosites on a peptide decrease the IEP; which can affect 850 
how the peptides are eluted. Furthermore, the MS detection and sequencing of these 851 
peptides is limited – particularly in a background of highly abundant non p-peptides and 852 
mono p-peptides. The additional phosphate residues reduce fragmentation efficiency, so 853 
the primary sequence of the peptide can be more difficult to determine; and the 854 
multiply charged peptides have severe suppression of ionization efficiency, which is 855 
caused by the co-existence of high abundance.  856 
A selection of techniques has been employed to address multi-phosphorylated peptides 857 
issues, including: 858 
(1) Improving operating conditions for conventionally used materials. Bae and 859 
colleagues noticed that selectivity of hydrazide functionalized monodispersed silica 860 
microspheres (HFMSM) [92] towards single or multiple p-peptides varied with the 861 
presence of different concentrations of formic acid (FA) in loading buffers. Lower 862 
pH/high acidity reduces the binding capacity of HFMSM towards both mono p-peptides 863 
and non-specific binding from acidic peptides. A higher concentration (1%, pH 2.4) of FA 864 
favored the enrichment of multiple p-peptides, whilst a lower concentration (0.02%, pH 865 
3.2) promoted detection of both [92].  866 
(2) The development of multi-p-peptides high binding capacity materials. Ti4+ ions have 867 
affinity towards single p-peptides, while mixed Ni2+/Zn2+, Ga3+ and Nb5+ ions show a 868 
preference for multi p-peptides. Compared to Ti4+-ATP (adenosine tri-phosphate)-MNPs, 869 
Ga3+-ATP-MNPs [93] was demonstrated to have higher selectivity and improved 870 
coverage (30% more) towards multi p-peptides from the tested rat liver mitochondria. It 871 
is speculated to be caused by the highly hydrophilic surface, where the immobilized Ga3+ 872 
provides suitable chelating strength for multi p-peptides, e.g. Fe3+-IMAC gel vs 873 




p-peptides is possible through the use of cerium-based nanocomposites: P-CCF (PEG–875 
Ce/CeO2–Fe3O4) can be used to extract mono p-peptides, and a CSF (Ce/CeO2–876 
SO42-/Fe2O3) probe can selectively enrich multiple p-peptides [94]. This technique 877 
benefits from the tight interactions between positively charged metal ions (Fe3+ and Ce4+) 878 
and the negatively charged phosphate group; and de-phosphorylation catalysed by CeO2 879 
[94]. 880 
(3) Design and introduction of multiple phosphate recognition units. Multi p-peptide 881 
enrichment for Zn2+-dipicolylamine complex-coated magnetic microspheres (ZnMMs) is 882 
enhanced due to both the large number of binuclear ZnDpa (the artificial receptor) 883 
binding sites, and a strong magnetic responsiveness on the microsphere’s surface [95]. 884 
Another example is the introduction of hydrogen bonding smart copolymer, which can 885 
modulate the adsorption/desorption of multi-p-peptides on enrichment material [90]. 886 
Most of these techniques that have been applied have been limited to the 887 
determination of peptides containing 2 or 3 phosphosites [14]. 888 
(4) Decreasing nonspecific binding through hydrophobic interactions. This can be 889 
achieved through the introduction of phosphate ion pre-coordinated Ti4+-IMAC [96]. The 890 
application of hydrazide, the amine-based functional group, aids the capture of 891 
p-peptides through electrostatic attraction and hydrogen bonding [92]; phosphoric 892 
acid-modified DZMOF showed improved selectivity toward multi p-peptides from both 893 
model proteins (α- and β-casein); and complex biological mixtures, where the 894 
identification number was increased from 605 (18.6%) to 1871 (70.1%) in HeLa cell 895 
lysate digests [67].  896 
(5) Combined usage of different materials or approaches. This approach is unavoidable 897 
as a benchmarking technique, as the overlapping p-peptides ranged from 59% to 79% 898 
when using the same materials for independent experiment, and jointly identified 899 
p-peptides only ranged between 16% and 52% when different MOAC materials were 900 




molecularly imprinted polymers (MIP) under identical experimental conditions [85]. 902 
However, TiO2 has certain limitations; for instance, it shows a bias towards identification 903 
of mono p-peptides, which will result in the incomplete information for the multi 904 
p-peptide section of the data. In addition, the matrix components of MOAC may hinder 905 
the successful purification of p-peptides, as pointed in the study of human whole blood 906 
samples or acute myeloid leukemia samples, where Ti4+-IMAC and Fe3+-IMAC 907 
outperforms either TiO2 beads, spin columns, or the graphitized carbon black-TiO2 908 
composite [97] toward multiple p-peptide detection. Thus, the combined application of 909 
IMAC and TiO2 termed SIMAC (sequential elution from IMAC) was reasonable [14]. 910 
Briefly, to increase the identification coverage of multiple p-peptides, the acidic and 911 
IMAC flow-through elution, which contains non-p-peptides and mono-p-peptides, were 912 
pooled and submitted for further TiO2 treatment, while the basic elution was analysed 913 
directly by LC-MS/MS [14]. Although SIMAC leads to more identification of multiple 914 
p-peptides [44], low enrichment efficiency from SIMAC (possibly due to the poor 915 
performance of MOAC) using an acute myeloid leukemia sample was found [44, 98].  916 
In conclusion, combining the advantages of different techniques, e.g. SIMAC strategy [14] 917 
or the synthesis of hybrid materials, the binary materials are promising for providing 918 
complementary phosphoproteomic information because of the excellent affinity 919 
towards both single- and multiple- p-peptides.  920 
3.3.2 Michael addition  921 
Compared to affinity-based enrichment methods, chemical modifications have high 922 
specificity [7]. There are a range of chemical modifications available, including 923 
β-elimination, carbodi-imide condensation, oxidation-reduction condensation, and 924 
α-Diazo resin; which all functionally replace the phosphate group with another chemical 925 
group that can be targeted specifically. A typical example of this is β-elimination, in 926 
which the phosphate group of phospho -serine or -threonine is eliminated through the 927 




This process is coupled with the addition of propanedithiol (the Michael addition), which 929 
covalently binds to thiols and introduce free SH groups for enrichment. Phosphate 930 
elimination during MS analysis prevents neutral loss, retains the intact peptide 931 
sequence-which is useful for identification - and increases the ionization efficiency for 932 
MS positive ion mode [99]; however, chemical treatments can result in both sample loss, 933 
due to multiple reaction steps, and the increase in sample complexity resulting from 934 
incomplete and side reactions [7].  935 
3.3.3 Anti-tyrosine antibodies 936 
As mentioned above, pTyr sites make up a smaller fraction of the p-proteome, and are 937 
often under-represented due to sampling bias. Commercially available anti-tyrosine 938 
antibodies have a high affinity for pTyr and can be used for selective enrichment of pTyr 939 
peptides; but poor reproducibility, low sensitivity, and limited availability/variability of 940 
antibody/bulk starting materials limit enrichment capacity - particularly for complex 941 
peptide mixtures [100], and high costs limit their wider application [101]. To solve the 942 
affinity specificity and quantification accuracy issue caused by sequence bias, pTyr 943 
antibody cocktails (combined different pTyr antibodies together) have been proposed 944 
[102]. A replacement biological-capture method has also been reported: where a pTyr 945 
super-binding protein domain, created by introducing 3 point mutations into the pTyr 946 
binding pocket of the pTyr binding SH2 domain of the Src protein, captures the pTyr 947 
peptides, which are then eluted using a competitive elution agent, biotin-pYEEI 948 
(pTyr-Glu-Glu-Ile) [101]. This technique, however, is limited by the biotin-pYEEI used to 949 
elute pTyr from the SH2 super-binder, as it must be removed from the sample before 950 
LC-MS/MS analysis. The additional purification step results in significant sample loss 951 
[103]. The low recovery of these biological enrichment methods limits their applications 952 




3.3.4 Incorporation of phosphate recognition artificial receptors 954 
Compared to conventionally used ligands, the incorporation of the binuclear 955 
Zn2+-dipicolylamine complex-coated ZnDpa as a phosphate-selective artificial receptor, 956 
greatly improved the p-peptide enriched efficiency [95]. As a result, the detection limit 957 
through using ZnDpa was 250 fmol for β-casein. Advances of ZnDpa are high affinity and 958 
specificity toward phosphate groups, contributing to the resolution of non-specific 959 
binding from acidic or basic residues issues [95]. The introduction of artificial receptors 960 
with the incorporation of materials with multiple binding sites may shine light on the 961 
interpretation of comprehensive phosphoproteome research. However, this enrichment 962 
testing was only carried out towards p-peptides from tryptic digests of standard proteins 963 
β-casein/BSA, and as mentioned above, requires further validation with true (more 964 
realistic) biological samples. 965 
3.3.5 IMAC or MOAC with antibody-based treatment 966 
Possemato et al. reported that only less than 5% overlapped phospho-sites were 967 
obtained upon the application of TiO2 and immunoaffinity precipitation (IAP) with 968 
different antibodies (pY-, pAKT/AMPK-, pATM/R-, and pST) treatment, which indicate a 969 
pS:pT:pY ratio approximated at 90:10:<1 for TiO2, but 51:29:20 for IAP data [104]. The 970 
low overlap between IMAC, MOAC and pTyr antibody has also been observed elsewhere 971 
[15], indicating the importance of a combined strategy. The SH2 super-binder 972 
enrichment strategy has been combined with IMAC with Ti4+-IMAC [103], and an 973 
updated one-step SH2 super-binder method [105], as well as in a biphasic affinity 974 
chromatography approach, where Src SH2 super-binder was coupled with NeutrAvidin 975 
affinity chromatography, which resulted in enhanced specific selectivity [106]. 976 
3.3.6 Use of IMAC in combination with other techniques 977 
Previously, the incorporation of TiO2 with SIMAC has been found to improve the 978 
phosphoproteome coverage [107]. Further, the application of combining of different 979 




p-peptide enrichment techniques (e.g. Fe-IMAC with p-peptide precipitation by CaCl2, 981 
pTyr phosphotyrosine immunoprecipitation and methyl esterification, as well as 982 
β-elimination) have been proven to be superior to the one step IMAC enrichment 983 
approach [14].  984 
3.3.7 MOAC-TiO2 with other techniques 985 
The combination of phosphotyrosine-imprinted polymer with TiO2 (pY-MIP-TiO2) shed 986 
light on the study of pThr and pTyr, based on the finding that pY-MIP-TiO2 protocol 987 
caused comparable identification numbers with TiO2 alone, with enhanced ion signal 988 
intensities for pThr and pTyr, but not pSer [100]. Moreover, the incorporation of 989 
alternative β-elimination followed by the Michael approach is required for the precise 990 
assignment about the location of multisite-phosphorylated (especially higher than 991 
triply-phosphorylated peptides) Ser/Thr-rich regions after the MS detection of p-peptides 992 
using TiO2 treatment [108], for which the presence of high number of phosphorylated 993 
residues on the same peptide decrease the IEP and thus challenge MS sequencing and 994 
detection. In addition, the combination of conventional TiO2 with novel developed 995 
hydrogen bonding-based polymeric material was recommend for p-peptides enrichment 996 
[90], from which the latter may facilitate the discovery of high proportions of pThr and 997 
pTyr, particularly from multi-p-peptides.  998 
3.3.8 Simultaneous detection of p-peptides and other PTMs 999 
Phosphorylation and glycosylation are of the most ubiquitous PTMs, which are highly associated 1000 
with various biological processes. Previous studies demonstrate crosstalk between the two PTMs 1001 
[109], and so efforts have been made to improve the simultaneous detection of phosphorylation 1002 
and other PTM, for example glycopeptides. A typical diagram of p-peptide and glycopeptide 1003 
enrichment is shown in Fig. 5. Co-enrichment can be achieved either through using materials 1004 
with various capabilities for different PTMs enrichment, or through fabricating nanomaterials 1005 
that possess properties of both p-peptide enrichment (IMAC or MOAC) and glycopeptide 1006 




amino functioned [110], hydrophilic interaction liquid chromatograph for hydrophilic interaction 1008 
[111], and boronic acid affinity for SPIOs@SiO2@MOF (boronic acid-functionalized magnetic 1009 
organic framework Zr-MOF nanocomposites, as shown in Fig. 5a) [112]. The good 1010 
biocompatibility, excellent hydrophilic property and a large amount of Ti4+ endows the de novo 1011 
synthesis of nanomaterials with great promise for the identification of low abundance N-glyco 1012 
/p-peptides. The material can be ‘tunable’ for p-peptide or N-glyco peptides ie be used for 1013 
simultaneous or independent selection steps using different enrichment conditions, exemplified 1014 
by application MagG@PEI@PA-Ti4+ to HeLa cell extracts [51].  1015 
Other approaches utilize the affinity between glycan chains and TiO2 or NH2 hydrophilic 1016 
interaction such as SiO2-NH2@TiO2 hollow microspheres [113], 1017 
TiO2@SiO2-B(OH)2@Fe3O4@ TiO2 sandwich-like nanosheets [114] (as shown in Fig. 5b), 1018 
Fe3O4@Au-B(OH)2@mTiO2 core-shell microspheres [115], TiO2-NH2 modified MALDI 1019 
plate (stability and reusability) [116] (Fig. 5c). These enhanced materials will help shed 1020 
new light on phospho- and N-glyco- proteome research.  1021 
4. Summary and Perspectives 1022 
Challenges remain to establish the key goal of a single step enrichment that 1023 
comprehensively captures all p-peptides in a sample, whilst also generating a sample that is 1024 
compatible with LC-MS/MS with minimal processing. As the p-peptide/p-peptide plus other PTM 1025 
enrichment efficiency varies between different techniques, it is strongly recommended that a 1026 
chosen method is necessarily optimized for each new sample. It is important to decide 1027 
on the focus or target of the enrichment in terms of the specific research question, since, in 1028 
terms of current methodologies, “one size” may not fit all. The key conclusion from 1029 
reviewing the latest literature in this field is that phosphoproteomic coverage is 1030 
significantly improved by a combination of different methodologies. Specifically, the 1031 
coverage of enrichments with different materials (ions or oxides) is higher than that for 1032 




materials synthesized from metal ions/oxides showed excellent enrichment 1034 
performances compared to the component parts. Studies with novel formats are 1035 
provided in Table format (Tables S1-S4) for 51 publications, with information on the 1036 
material, test samples (tryptic or Lys-C, trypsin digests), reported sensitivity and 1037 
selectivity, sample matrix and MS instrumentation. This finding appears to be the result 1038 
of the synthesized composites possessing a relatively higher surface area, good aqueous 1039 
dispersibility, and excellent magnetic responsiveness. Hybrid materials have been 1040 
devised that utilise complementary features, addressing the inherent limitations that 1041 
arise from intrinsic physiochemical properties of existing methods. For example, 1042 
substrate ligands that have stability in strong alkaline and acid buffers, and exhibit 1043 
hydrophilicity to minimize nonspecific binding. Materials using artificial receptors, for 1044 
multiple phosphate-selective binding sites, also show promise. 1045 
Identifying the key factors affecting the p-peptide enrichment performance of affinity 1046 
materials has led to optimization of: solvent tolerance, pore size, functional groups, and 1047 
surface area within the materials. Furthermore, through the addition of various organic 1048 
acids as non-p-peptide inhibitors, control of the peptide/enrichment material ratio, and 1049 
use the optimal pH within the elution buffer as process parameters further improves 1050 
enrichment efficiency. The identified parameters are not silver bullet solutions, and 1051 
consideration should to be taken depending on the target of the study – for example, 1052 
the specific affinity of different materials towards p-peptides varies in the presence of 1053 
additives. Despite this, materials are gradually becoming available for unbiased sample 1054 
preparation for protein analysis, such as solid-phase-enhanced sample-preparation (SP3) 1055 
technology. SP3 is a paramagnetic bead-based approach for rapid, robust, and efficient 1056 
processing of protein samples for proteomic analysis. This bead format utilizes 1057 
hydrophilic interaction to mediate exchange or removal of components used for 1058 
proteomic analysis [117]. Use of such materials have potential for widespread adoption, 1059 




It is important to note that recent developments in MS analysis and peptide spectral 1061 
matching algorithm aid phosphoproteome analysis. The use of ion mobility (IM) MS 1062 
provides additional separation to mass-to-charge (m/z) based on structure/shape 1063 
(collisional cross section). IM separations occur at a millisecond timescale and this 1064 
couples effectively with LC-MS to increase separation of co-eluting peptide isomers with 1065 
variant modified sites [99]. The recently developed method for structures for lossless ion 1066 
manipulations ion mobility offers improved sensitivity and separation of p-peptides, in 1067 
particular for resolution of p-peptide isomers, with application to discovery and targeted 1068 
phosphoproteomic workflows [118]. Capillary Electrophoresis, which separates based on 1069 
the size-to-charge ratio of the peptide – with sensitivity to charge state, is well suited to 1070 
the study of PTMs, including phosphorylation. Coupling this approach to MS has brought 1071 
gains in phosphoproteome coverage as exemplified by studies of mouse brain [119] and 1072 
a colon cancer cell line [120]. 1073 
Novel developed sorbents, especially micro/nanocomposites show great promise for 1074 
phosphoproteomics; however, further exploration is needed before their large-scale 1075 
practical application, due to the very limited data on true biological samples. Current 1076 
data are generally limited towards a “standard” (simple) protein mixture (typically casein 1077 
and BSA), with some limited reference to testing on samples representative of true 1078 
biological samples - HeLa cell lysates or human body fluids (saliva, serum). Tests involve 1079 
mixing of peptides derived from trypsin or Lys-C, trypsin digests of α and β isoforms of 1080 
caseins/BSA ratio of 1:49 or 1:99 (w/w), selected as representative of the low 1081 
stoichiometry of phosphoproteins typically seen in biological samples such as cell 1082 
lysates. The limitation of this approach is that it lacks the complexity of the p-peptides 1083 
derived from a cellular phosphoproteome. In addition, p-peptides derived from α and β 1084 
casein generally contain acidic residues, are phosphorylated at stoichiometric levels, and 1085 
have a multiple charge state, which limits how representative they are to p-peptides 1086 
found in complex biological samples. Such studies are a good starting point, but are not 1087 




experience in different sample types. Many of the novel materials discussed in this 1089 
paper were tested using MALDI sources (Supplementary Tables S1-4); however, ESI 1090 
(electrospray ionization) is the primary ionisation source for many phosphoproteomic 1091 
investigations. Unlike MALDI MS, LC-ESI MSMS is biased toward mono-phosphorylated 1092 
peptides[121], so for representative results it is important that ‘head to head’ method 1093 
comparisons are performed on the same LC-MS/MS system. Phosphoproteomic 1094 
protocols can also benefit from developments in new materials, fractionation protocols 1095 
such as UPAX for canonical and non-canonical p-peptide separation from 1096 
non-phosphorylated peptides [108], widening the scope of phosphoproteomic analysis 1097 
to include acid labile phosphorylation which have been under-reported due to lack of 1098 
detection in pSer/PThr/pY directed workflows [122]. Ultimately, for the new materials 1099 
and processes mentioned here to become widespread and provide true benefit to the 1100 
field of phosphoproteomics, rigorous bench marking is needed against the widespread 1101 
classical methods of p-peptide enrichment currently available; and the ‘winners’ of such 1102 
tests must also be affordable and commercial available.   1103 
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Figure Legends 1494 
Graphical abstract: Schematic diagram for p-peptide enrichment strategies. Ti4+ 1495 
lab-in-syringe polydopamine coated three-dimensional porous graphene aerogel 1496 
sorbent carrying immobilized titanium (IV) ions (denoted as Ti4+@PDA@GA [53]), 1497 
Phos-PAD: p-peptide paper-based analytical devices [72], graphene 1498 
oxide-trimethyl-2-methacroyloxyethyl ammonium chloride-titania (GO-META-TiO2) [64]. 1499 
PolyMAC: (polymer-based metal ion affinity capture) [86, 87]. Phosphotyrosine antibody 1500 
cocktails [102]. Phosphotyrosine-imprinted polymer with TiO2 [100]. IMAC-antibody 1501 
(IMAC with phosphotyrosine antibody) [15]. High pH and pH step wise elution [15]. 1502 
Gradient elution: 100 mM NH4HCO3 (pH 9.2-11.3 step gradient and pH adjust by 1503 
ammonia [16]. Ti4+@PDA@GA) Adapted with permission [53]. Copyright 2018, Springer 1504 
Nature. Phos-PAD) Adapted with permission [72]. Copyright 2019, Elsevier. 1505 
GO-META-TiO2) Adapted with permission [64]. Copyright 2019, Elsevier. 1506 
 1507 
Figure 1 Sample preparation workflows for phosphoproteomics (a). The key steps are 1508 
“protein extraction”, “proteolytic digestion”, “p-peptide enrichment” and “fractionation” 1509 
[11]. The latest developments for sample preparation workflows aim to minimise the 1510 
number of processing steps, using robust and reproducible component methods. 1511 
Common strategies for p-peptide enrichment (b) [88]. (c) Main steps for affinity-based 1512 
p-peptide enrichment techniques. (d) Improvements for p-peptide enrichment. b) 1513 
Adapted with permission [88]. Copyright 2017, the Royal Society of Chemistry. 1514 
 1515 
Figure 2 Schemes for the creation and use of three novel enrichment materials: a) 1516 
MagG@PEI@PA-Ti4+, which can adsorb 53.5 μg mg-1 p-peptide with 90% recovery, and is 1517 
sensitive to concentrations as low as 0.8 fmol.μl-1 [49], b) Ti4+@PDA@GA, aerogel, 1518 
formed from graphene oxide (GO), is used in a lab-in-syringe methodology that 1519 
preferentially enriches p-proteins (1300-1345 μg mg−1 vs 4.8-160 μg mg−1), can adsorb 1520 




magG@PD-Hf4+, which showed sensitivity to concentrations as low as 0.08 fmol.μl-1 [47]. 1522 
All figures adapted with permission:  [49] Copyright 2018, American Chemical 1523 
Society; [37] Copyright 2018, Springer Nature; [47] Copyright 2016, Elsevier. 1524 
  1525 
Figure 3 Schemes for the creation and use of two novel MOAC formats: a) 1526 
Fe3O4@H-fTiO2 a functionalized TiO2 layer nanoparticle, with larger pore volumes (0.52 1527 
cm3g-1) and higher surface area (144.71 m2g-1) than existing TiO2 magnetic spheres, 1528 
showed a p-peptide:peptide selectivity ratio of up to 1:10000, and sensitivity down to 1529 
0.2 fmol.μl-1, (α-casein, BSA, HeLa cell) [64]. b) GF-TiO2-GO showed sensitivity down to 1530 
0.1 fmol.μl-1 and provided an unbiased mono-multi p-site peptide distribution in 1531 
concentrations of up to 0.2 μg.mg-1spheres (β-casein, BSA, non-fat milk and human 1532 
serum) [67]. Figures adapted with permission: [64] Copyright 2018, Elsevier; [67] 1533 
Copyright 2018, the Royal Society of Chemistry. 1534 
  1535 
Figure 4 Schemes for the creation and use of 3 IMAC/MOAC hybrid materials: a) 1536 
Fe3O4@n SiO2@m SiO2/TiO2-Ti4+ is sensitive to p-peptides from concentrations as low as 1537 
40 fmol.μl-1, has high surface area (179.3 m2g-1) and a selectivity ratio of 1:50, with an 1538 
adsorption capacity of 133 mg/g (β-casein, BSA, non-fat milk) [76]; b) TiO2@DOTA-Zr 1539 
showed sensitivity of as low as 10 μmol.μl-1, and a selectivity ratio of 1:10 (β-casein, BSA, 1540 
nonfat milk, human serum) [77]; and c) G@TiO2@mSiO2 showed a sensitivity of 1 1541 
fmol.μl-1 and a selectivity ratio of 1 to 1000 (α- or β- casein, BSA, human serum) [79]. 1542 
Adapted with permission: [76] Copyright 2017, Elsevier; [77] Copyright 2017, Elsevier; 1543 
[79] Copyright 2016, Elsevier. 1544 
  1545 
Figure 5 Typical workflow or schematic diagram of simultaneous N-glyco-peptide and 1546 
p-peptide (a-c). Magnetic materials of (a) SPIOs@SiO2@MOF (β-casein, BSA, IgG, rat 1547 
brain, rat liver) [109], (b) TiO2@SiO2-B(OH)2@Fe3O4@TiO2 (β-casein, BSA, horseradish 1548 




loading buffer (50% ACN, 0.1% or 0.25% TFA, v/v), washed 3 times, and then eluted by 1550 
ammonia solutions (0.4 M or 10% wt%) after 30 min’s treatment. (c) TiO2-NH2 modified 1551 
MALDI plate (β-casein, BSA, horseradish peroxidase, human serum, human saliva) [113], 1552 
for which 5 min of incubation (50% ACN, 1% TFA, or 95% ACN, 0.1% TFA, v/v), after 5 1553 
times washing, DHB was added for direct LC-MS/MS analysis. Reproduced from [109] 1554 
Copyright 2019,American Chemical Society; [111] Copyright 2016, Springer Nature; [113]. 1555 
Copyright 2017, Elsevier. 1556 
 1557 
Supporting files 1558 
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Table S1 Comparison of p-peptide enrichment by immobilized metal ion affinity 1560 
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Table 1. Existing formats for metal based p-peptide enrichment.  1568 
Technique/ 
Example format 




(1) TiO2 material pre-condition according to manufacturer’s 
instructions, eg. wash with condition buffer; 
(2) Desalted peptides incubate with magnetic TiO2 beads for 
30 min with the presence of 1M lactic acid or glycolic acid; 









Iron Affinity Gel 
beads pack into 
microcolumn) 
(1) Microcolumn preparation: gel beads were pipetting into 
special tips; the tips were then place into centrifuge 
adaptor; and conditioned before use. 
(2) Peptides were incubated with gel beads for 30 min. 
 
Unbound 
peptides   
removed using 
wash buffer 
250 mM  
acetic acid 
with 30% ACN  
 
Bound peptides were released 
into 250 mM acetic acid pH 3.0 








Elute by syringe with buffer 





tip (2) Condition the Phos-tag tip; 
Draw sample.  gently into the micropipette-tip by using 1 ml 
syringe and agarose beads in suspension was kept for a few 





M CH3COOH (pH 7.0) or 0.1 M 
aqueous HCl, 2% aqueous (v/v) 
TFA, 5% aqueous NH3, or 0.10 
M EDTA/NaOH (pH 7.0) 
PolyMAC 
reagent 
(-Ti or -Fe)  
(1) Synthesis of PolyMAC reagent; 
(2) Peptides incubate with PolyMAC reagent for 5 min, and 
add capture buffer; 
(3) Transfer mixture to spin column with washed resin and 
incubate for 10 min with agitation; 










Table 2 Example p-peptide enrichment protocols published in the last five years, these can form user guides due to full and detailed 1569 
protocols considering theoretical and practical aspects of workflow design and application 1570 















Multiplex analysis  







5% directed to 
Proteomic analysis 






















analysis using dimethyl 
labelling 










Protocol for with 
universal 
application to plant 
samples 
[21] 












for 1 mg) 






















of peptide material 
 






















50-150 mg starting 
wet tissue 





of pSer, PThr 
MOAC-TiO2 
 







the value of 
experimental 
design, use of 
replicates in 
analysis of clinical 
samples  
[36] 
pY peptides using specific phosphotyrosine antibodies and TiO2. We also describe the enrichment of phosphoserine/threonine (pST) 1571 




Supporting Tables 1573 






Mono Multi Real sample matrix Instrumentation Ref 
Fe3O4@PDA- Nb5+ 2 fmol 1:100 5 11 non-fat milk MALDI-TOF/TOF (AB 
Sciex 5800) 
[46] 
Fe3O4@PDA-Ti4+ 2 fmol 1:100 5 9 non-fat milk 
Fe3O4@PDA-Zr4+ 80 fmol 1:100 4 7 non-fat milk 
Fe3O4@PDA-Ce4+ 2 fmol 1:50 5 6 non-fat milk 
Fe3O4@PDA-Ga3+ 20 fmol 1:100 4 7 non-fat milk 
Fe3O4@PDA-Y3+ 80 fmol 1:50 2 5 non-fat milk 
Fe3O4@PDA-In3+ 200 fmol 1:50 4 5 non-fat milk 
Fe3O4@PDA-Fe3+ 200 fmol 1:50 5 6 non-fat milk 
Fe3O4@PDA- Nb/Ti binary 
composite 
2 fmol 1:1000 8 11 human serum, nonfat 
milk 
MALDI-TOF-MS [48]  
Urea-modified MIL-101 
(Cr)-Amine based affinity 











Real sample matrix Instrumentation Ref 
Ti4+@PDA@GA 30  1:200 milk, human serum MALDI-TOF-MS [53] 
magG@PDA-Hf4+ 
0.08  1:500 non-fat milk, human 
serum 
MALDI-TOF-MS 
(AB Sciex 5800) 
[49] 
magG@PDA-Sn4+ 




0.2 * 1:5000* HeLa cell MALDI-TOF-MS 
(AB Sciex 4800 plus) 
[125] 
magSiO2@SiO2@PDA@Ti(IV) 
0.05 1:500 human serum MALDI-TOF-MS 
(Voyager-DE PRO) 
[56] 
Fe3 O4 @mSiO2-Ti4+ 
0.1  1:500   human serum, saliva MALDI-TOF/TOF 
(AB Sciex 5800) 
[47] 
Fe3O4@SiO2-PLP-Ti4+ 10 fmol,  
1:500 non-fat milk, human 
serum  
MALDI-TOF (Axima TOF2), and 







- 1:100 yeast Orbitrap Elite hybrid ion 
trap-Orbitrap-MS 
[55] 
CF-NH2-AZO-p(VPA-x)-Ti4+   1 × 10−4 
1:100 non-fat milk, human 





monolith 0.001  
1:1500 human serum MALDI-TOF-MS 
(Voyager‐DE PRO) 
[127] 
Ti-PA-MNPs 8 × 10−4  1:2000 rat liver MALDI-TOF-MS [128] 











Real sample matrix Instrumentation Ref 
In2O3, SnO2, NiO, Co3O4 
- - human embryonic kidney 
cell line 
Orbitrap XL or Orbitrap Elite [43] 
MoO3/GO 1 × 10−3 
1:1000 
nonfat milk, human serum 
MALDI-TOF/TOF 
(AB Sciex 5800) 
[60] 











nonfat milk, human serum 
MALDI-TOF-MS/MS 
(AB Sciex 4800 plus) 
[129] 
Zirconia/OMC 
1.5 1:300 non-fat milk MALDI-TOF-MS/MS 
(AB Sciex 4800 plus) 
[130] 
In-Tip La2O3 monolith 







Table S2B Comparison of p-peptide enrichment by metal oxide affinity chromatography (MOAC) for different supporting ligands  1581 
Materials Sensitivity Selectivity 
β-casein:BSA 
digests (n:n) 
Real sample matrix Instrumentation Ref 
TMA-microchips (TiO2)  0.4 1:100 egg white MALDI-TOF-MS [71] 
Fe3O4@H-fTiO2 




- 1:100 yeast Orbitrap Elite hybrid ion trap-Orbitrap 
MS 
[66] 
GO-META-TiO2  10  1:100 chicken egg white MALDI-TOF-MS [64] 
CIM-OH-TiO2 
- - cytochrome C, lysozyme, 
human serum 
LTQ Velos ion-trap MS [69] 
GF-TiO2-GO 
1 × 10−5 1:100 non-fat milk, human 
serum 
MALDI-TOF-MS [65] 
mesoporous TiO2 in‐ tube solid‐
phase microextraction column 
10  1:100 non-fat milk MALDI-TOF-MS [132] 











Real sample matrix  Synthesis Instrumentation Ref 
TiO2/Bi/Fe/Zr 4 × 10-4 1:1000 Hela cell sol-gel method MALDI-TOF/TOF (AB 
Sciex 5800) 
[58] 
B0.15F0.15TNs  2 × 10-3 1:1200 human liver sol-gel method MALDI-TOF/TOF (AB 
Sciex 5800) 
[59] 
MnFe2O4 MAMSs 1  1:500 non-fat milk, human 
serum 
solvothermal route MALDI-TOF-MS 
(AB Sciex 4800) 
[75] 
CuFeMnO4  
nanospheres affinity probe 
20  1:100 nonfat milk, A549 
cells, human saliva, 
human serum 
solvothermal route MALDI-TOF-MS 
(AB Sciex 4800) 
[133] 
Fe3O4@PDA-Ti/Nb 2  1:1000 non-fat milk, human 
serum 
- MALDI-TOF-MS [48] 









serum/HeLa cell (AB Sciex 4800 plus) 
PAA-Ti/TiO2 composite 2  1:1000 human serum, 
mouse liver 
- MALDI-TOF/TOF (AB 
Sciex 5800) 
[80] 
TiO2@DOTA-Zr  1×10−7 1:10 nonfat milk, human 
serum 
macrocyclic ligand  MALDI-TOF/TOF [79] 
magG/PD/(Zr-Ti)O4 4.0 × 10-5 1:8000 
weight ratio 
mouse brain tissue magnetic/graphene MALDI-TOF MS [76] 
G@TiO2@mSiO2 1  1:1000; human serum magnetic/graphene/ 
mesoporous silica 




Al2O3 - TiO2/ ZrO2/CeO2/ La2O3 10  1:1000; human serum co-precipitation MALDI-TOF/TOF 
(Ultraflex-I) 
[77] 









Real sample matrix Instrumentation Ref 
 P G P G    
SiO2-NH2@TiO2  0.16  2  1/500 1/500 human serum albumin 
MALDI-TOF 
(AB Sciex 5800) 
[113] 












(AB Sciex 5800) 
[115] 
TiO2-NH2 modified MALDI plate 8  20  1/200 1/100 human serum/saliva 
MALDI-TOF 
(AB Sciex 5800) 
[116] 




Fe3O4@PDA@UiO-66-NH2 (Zr3+)  0.02  0.2   1/500 1/100 human serum 
MALDI-TOF 
(AB Sciex 5800) 
[135] 
MagG@PEI@PA-Ti4+ 0.1* 0.5#    1/5000* 1/1000# human serum 






Mag-MSMs@PEI-PA-Ti4+ 0.2* 0.5 #   1/5000* 1/1000# human serum, HeLa cell  
MALDI-TOF (AB Sciex 
4800 plus) 
[111] 
Fe3O4@MIL-100(Fe)  0.1 0.1  1/50 1/20 human saliva 
MALDI-TOF 
(AB Sciex 5800) 
[136] 
co-PAN@Ti4+ 4  100  1/50 1/50 human serum 
MALDI-TOF 
(AB Sciex 5800) 
[137] 




SPIOs@SiO2@MOF 10−4 10−5 1/400 1/500 
rat brain, rat liver, 
mouse liver 
MALDI-TOF 
(AB Sciex 5800) 
[112] 
a: β-casein/BSA for P; horseradish peroxidase/BSA for G. *: data from α-casein/BSA; #: data from IgG/BSA. 1587 
PGMA: poly glycidyl methacrylate.  1588 
